| Primary |
| Product Used For Unknown Indication |
100.0% |
|
| Drug Hypersensitivity |
100.0% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
20.0% |
| Cholesterosis |
13.3% |
| Contraception |
13.3% |
| Hirsutism |
13.3% |
| Hormone Therapy |
13.3% |
| Pain |
13.3% |
| Thrombosis Prophylaxis |
13.3% |
|
| Unintended Pregnancy |
100.0% |
|
| Concomitant |
| Pain |
18.8% |
| Product Used For Unknown Indication |
15.8% |
| Prophylaxis |
9.3% |
| Rheumatoid Arthritis |
5.8% |
| Constipation |
5.0% |
| Diffuse Large B-cell Lymphoma |
4.4% |
| Hypertension |
4.4% |
| Nausea |
4.4% |
| Mental Disorder |
4.0% |
| Surgery |
4.0% |
| Drug Use For Unknown Indication |
3.8% |
| Depression |
3.7% |
| Vitamin Supplementation |
2.7% |
| Crohn's Disease |
2.4% |
| Laxative Supportive Care |
2.3% |
| Sedative Therapy |
2.1% |
| Ankylosing Spondylitis |
1.8% |
| Hypercholesterolaemia |
1.8% |
| Non-small Cell Lung Cancer |
1.8% |
| Diuretic Therapy |
1.7% |
|
| Weight Increased |
9.8% |
| Intestinal T-cell Lymphoma |
7.3% |
| Malaise |
7.3% |
| Atrial Fibrillation |
6.1% |
| Death |
6.1% |
| White Blood Cell Count Decreased |
6.1% |
| Blood Bilirubin Increased |
4.9% |
| Hyponatraemia |
4.9% |
| Loss Of Consciousness |
4.9% |
| Sudden Death |
4.9% |
| White Blood Cell Count Increased |
4.9% |
| Cerebral Infarction |
3.7% |
| Hyperkalaemia |
3.7% |
| Malignant Melanoma |
3.7% |
| Osteonecrosis |
3.7% |
| Pulmonary Tuberculosis |
3.7% |
| Rhabdomyolysis |
3.7% |
| Squamous Cell Carcinoma Of Skin |
3.7% |
| Upper Limb Fracture |
3.7% |
| Vomiting |
3.7% |
|
| Interacting |
| Pain |
85.7% |
| Hypothyroidism |
14.3% |
|
| Urine Colour Abnormal |
100.0% |
|
